SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-306672
Filing Date
2014-08-12
Accepted
2014-08-12 16:18:17
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d756954d10q.htm 10-Q 312857
2 EX-10.1 d756954dex101.htm EX-10.1 19374
3 EX-31.1 d756954dex311.htm EX-31.1 5991
4 EX-31.2 d756954dex312.htm EX-31.2 6011
5 EX-32 d756954dex32.htm EX-32 5212
  Complete submission text file 0001193125-14-306672.txt   3066583

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT itci-20140630.xml EX-101.INS 431971
7 XBRL TAXONOMY EXTENSION SCHEMA itci-20140630.xsd EX-101.SCH 27756
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20140630_cal.xml EX-101.CAL 37970
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20140630_def.xml EX-101.DEF 82447
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20140630_lab.xml EX-101.LAB 252361
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20140630_pre.xml EX-101.PRE 166818
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 141034169
SIC: 2834 Pharmaceutical Preparations